| Autor: |
Yılmaz ŞG; Department of Nutrition and Dietetics, Health Sciences Faculty, Gaziantep University, Gaziantep, Turkey., Almasri S; Department of Biochemistry Science and Technology, Gaziantep University, Turkey., Karabulut YY; Department of Pathology, Medical Faculty, Mersin University, Mersin, Turkey., Korkmaz M; Department of Medical Biology, Medical Faculty, Islam Science and Technology University, Gaziantep, Turkey., Bucak Ö; Department of Medical Biology, Medical Faculty, Mersin University, Mersin, Turkey., Balcı SO; Department of Medical Biology, Medical Faculty, Gaziantep University, Gaziantep, Turkey. |
| Abstrakt: |
Alzheimer's disease (AD) is a neurodegenerative disease characterized by progressive memory loss and cognitive decline, with hallmark pathologies related to amyloid beta (Aβ) and TAU. Natural phytochemicals show promise for drug discovery to fill the current therapeutic innovation gap in AD. This study investigated the effect of cucurbitacin E (CuE), one of the bioactive components of Ecballium elaterium , on TAU fibril formation in okadaic acid-induced AD in rats. In a randomized design, we assigned 30 female Sprague Dawley rats to one of five experimental groups: (1) control, (2) stereotaxic surgery, (3) stereotaxic surgery + artificial cerebrospinal fluid, (4) stereotaxic surgery + okadaic acid (AD model), and (5) stereotaxic surgery + okadaic acid + CuE treatment. For experimental groups 4 and 5, rats were administered OKA-ICV (200 ng/kg) followed by CuE (4 mg/[kg·day], intraperitoneally) for 20 days. Expression of the MAPK1/3 and MAPK14 genes associated with TAU metabolism, hippocampal protein levels of these genes, cognitive functions of the rats, and histological accumulation of TAU in the brain were evaluated. Our findings in this preclinical model collectively suggest that phytochemical CuE contributes to memory gain by reducing TAU protein accumulation, which warrants further evaluation in future in vitro and in vivo studies. |
